FundedIQ
Biotechnology

Ubives: Funding, Investors & Team (Oct 2026)

Ubives is an innovative user management tool that transforms the way online identification and data management are handled. It eliminates the need for passwords, making logins easier and reducing security risks. By seamlessly integrating with various services and systems, it offers businesses substantial cost savings compared to traditional identification methods. Its goal is to enhance online security and convenience by providing cutting-edge solutions for digital identity management.

www.ubives.com LinkedIn Budapest, Hungary 1-10 employees
Biometrics Cloud Management Cloud Security Cyber Security Identity Management Private Cloud SaaS B2B
Total raised
$10k
Rounds
1
Latest
Pre-Seed
Jul 2024

Ubives has raised $10k across 1 funding round on record, the most recent a Pre-Seed of $10k announced in Jul 2024.

That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Ubives Company Profile and Key Stats

Total funding raised
$10k
across 1 round on record
Funding rounds on record
1
Latest funding round
Pre-Seed
$10k in Jul 2024
Employees
1-10
reported band
Headquarters
Budapest, Hungary

Latest funding round on record: Jul 2024.

Ubives Funding Rounds

Date
Round
Amount
Pre-Seed
$10k

Ubives Founders and Leadership Team

Name
Role
Contact
Marcel Nyiro
Founder
Locked

Contact details for the Ubives team: 1 of 1 has an email address on file.

Start 14-day free trial →

Ubives Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
42
$7.2M
6,021
$600K

Ubives' latest round of $10k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Ubives in Biotechnology and Budapest

Companies Similar to Ubives

VRG Therapeutics is a biotech firm specializing in miniprotein-based drugs and cellular and gene therapy…

Series A $5.5M
Series B $150M

BioLinker is a creation of manufactured science, protein blend packs, and protein.

Undisclosed round $1.7M

WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs…

Series B $26.0M

Tydra Labs is a biotechnology company that transforms crustacean shell waste into chitin and bio-products.

Seed $420k

M-Based develops new alternative material technologies using mushrooms. 🍄 We consider environmental…

Seed $700k

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Turning biomass residues into fit-for-purpose microbial fertilizers, biostimulants and biocontrols.

Series A —

R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…

Series A $3.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Ubives Funding FAQs

What does Ubives do?

Ubives is an innovative user management tool that transforms the way online identification and data management are handled. It eliminates the need for passwords, making logins easier and reducing security risks. By seamlessly integrating with various services and systems, it offers businesses substantial cost savings compared to traditional identification methods. Its goal is to enhance online security and convenience by providing cutting-edge solutions for digital identity management.

How much funding has Ubives raised?

Ubives has raised $10k across 1 round on record. The most recent is a Pre-Seed of $10k announced in Jul 2024.

When did Ubives last raise funding?

Ubives' most recent funding round on record is a Pre-Seed of $10k, announced in Jul 2024.

Who founded Ubives?

FundedIQ lists Marcel Nyiro (Founder) at Ubives.

Where is Ubives headquartered?

Ubives is based in Budapest, Hungary.

How many employees does Ubives have?

Ubives is in the 1-10 employee band.

How does Ubives' funding compare to other Biotechnology startups?

Ubives' latest round of $10k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Ubives Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Ubives is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.